✦ LIBER ✦

S22.2 Serological and molecular advances in clinical laboratory testing for hepatitis viruses

Book ID: 119563899
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 111 KB
Volume: 26
Category: Article
ISSN: 0924-8579
DOI: 10.1016/s0924-8579(05)80101-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A 31-mutation assay for cystic fibrosis

A 31-mutation assay for cystic fibrosis testing in the clinical molecular diagnostics laboratory

✍ Jeff Wall; Shiping Cai; Farid F. Chehab 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 654 KB

## Communicated by Arthur L. Beaudet We devised a set of allele-specific probes to detect simultaneously 3 1 known cystic fibrosis mutations using PCR and the reverse dot blot detection format. The assay has been implemented in a clinical setting to the screening of over 750 individuals. Of these

Serological and molecular screening for

Serological and molecular screening for viruses in blood donors from Ntcheu, Malawi: High prevalence of HIV-1 subtype C and of markers of hepatitis B and C viruses

✍ D. Candotti; C. Mundy; G. Kadewele; W. Nkhoma; I. Bates; J.-P. Allain 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

The prevalence of antibodies to human immunodeficiency virus type 1 (HIV-1), hepatitis C virus (HCV), human T lymphotropic virus I (HTLV-I), and hepatitis B (HBV) surface antigen (HBsAg) was determined in blood donors from Ntcheu, Malawi. Each donation was also screened for HIV-1 RNA and HCV RNA. Am